The global Monoclonal Antibody Therapeutics Market is estimated to be valued at US$ 205,385.6 million in 2022 and is expected to exhibit a CAGR of 12.69% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
